Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Margiotta

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Alimentary Pharmacology & Therapeutics|October 4, 2005
DNA sequences and proteic antigens of H. pylori in cholecystic bile and tissue of patients with gallstonesV Neri, M Margiotta, V de Francesco, et al.
Alimentary Pharmacology & Therapeutics|January 21, 2006
Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reactionV de Francesco, M Margiotta, A Zullo, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2004
Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failureV De Francesco, A Zullo, M Margiotta, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Alimentary Pharmacology & Therapeutics|October 4, 2005
DNA sequences and proteic antigens of H. pylori in cholecystic bile and tissue of patients with gallstonesV Neri, M Margiotta, V de Francesco, et al.
Alimentary Pharmacology & Therapeutics|January 21, 2006
Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reactionV de Francesco, M Margiotta, A Zullo, et al.
Alimentary Pharmacology & Therapeutics|February 12, 2004
Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failureV De Francesco, A Zullo, M Margiotta, et al.
Pageof 4